Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

<< Previous

Bullboard Posts

Next >>

Post by jwalliscaon Dec 07, 2020 9:36am

86 Views

Post# 32048543

Level II after Open at 9:35 am EST

SVA opened at $0.29... here we go...

Level II 9:35 am EST:

Number of Shares		Bid Price
40,000 shares	40,000	0.290
20,000 shares	20,000	0.285
114,500 shares	114,500	0.280
39,000 shares	39,000	0.275
25,500 shares	25,500	0.270
126,500 shares	126,500	0.265
66,000 shares	66,000	0.260
25,000 shares	25,000	0.255
50,000 shares	50,000	0.250
11,000 shares	11,000	0.240

Level two quotes - Ask
Ask Price	Number of Shares
0.295	67,000	67,000 shares
0.300	120,000	120,000 shares
0.305	91,500	91,500 shares
0.310	101,000	101,000 shares
0.315	10,000	10,000 shares
0.320	24,500	24,500 shares
0.325	10,000	10,000 shares
0.330	4,500	4,500 shares
0.335	14,500	14,500 shares
0.340	20,000